👤 Riping Wu

🔍 Search 📋 Browse 🏷️ Tags ❤️ Favourites ➕ Add 🧬 Extraction
1732
Articles
1210
Name variants
Also published as: Jiake Wu, Ming-Jiuan Wu, Siying Wu, Yijian Wu, Fong-Li Wu, Chih-Chung Wu, Jin'en Wu, Zhongwei Wu, Zixiang Wu, D P Wu, Haiping Wu, Geyan Wu, Qi-Zhu Wu, Jianjin Wu, Su Wu, Shwu-Yuan Wu, Xiaodi Wu, Changxin Wu, Kuen-Phon Wu, Guofeng Wu, Zhiping Wu, Xiaojun Wu, Qibing Wu, Cheng-Hsin Wu, Junhua Wu, Xiaoting Wu, Wenze Wu, Hong Wu, Yandi Wu, Zhong Wu, An-Chih Wu, Jianhui Wu, Xiaoke Wu, Zhenguo Wu, Jason H Y Wu, Bing-Bing Wu, Yi-Mi Wu, Selena Meiyun Wu, M Wu, Hui-Mei Wu, Danni Wu, Sijie Wu, Minqing Wu, Geng-ze Wu, Kun Wu, Cheng-Hua Wu, Shaofei Wu, Zhaoyang Wu, Qihan Wu, R Ryanne Wu, Kunling Wu, Hao Wu, Pei Wu, Mingxuan Wu, Wendy Wu, Yukang Wu, Jingtao Wu, Douglas C Wu, Guizhen Wu, Zhangjie Wu, Lili Wu, Jianwu Wu, Biaoliang Wu, Min-Jiao Wu, Huan Wu, Shengxi Wu, Fei-Fei Wu, Peih-Shan Wu, Guoqing Wu, Yu-Yuan Wu, Pei-Yu Wu, Jing Wu, Geting Wu, Lun-Gang Wu, Dongzhe Wu, G Wu, Junlong Wu, Jia-Jun Wu, Jiangyue Wu, Muzhou Wu, Ray-Chin Wu, Junzhu Wu, Jian-Qiu Wu, T Wu, Jianxiong Wu, Liping Wu, Haiwei Wu, Guoping Wu, Yong-Hao Wu, Jin-hua Wu, Yi Wu, Chongming Wu, You Wu, Xudong Wu, Qunzheng Wu, Liqiang Wu, Cuiling Wu, Kunfang Wu, Jason Wu, Bian Wu, Limeng Wu, Shuying Wu, Zhibing Wu, Caihong Wu, Naqiong Wu, Joseph C Wu, Huating Wu, Tianhao Wu, Zhi-Hong Wu, Congying Wu, Gaojun Wu, Chiao-En Wu, Dongping Wu, Li Wu, Yihang Wu, Shaoxuan Wu, Haixia Wu, Gen Wu, Fanchang Wu, Xiaorong Wu, Mingjie Wu, Mei Wu, Jiahao Wu, Jiapei Wu, Lingqian Wu, Jia Wu, Fangge Wu, Sen-Chao Wu, Yanhui Wu, Zhiqiang Wu, Shugeng Wu, Sarah Wu, Xuanqin Wu, Dongmei Wu, Caiwen Wu, Junjing Wu, Jiangdong Wu, Guihua Wu, Yingbiao Wu, Meini Wu, Rui Wu, Hua-Yu Wu, Bifeng Wu, Jingwan Wu, Lingling Wu, Xinmiao Wu, Junzheng Wu, Yi-Fang Wu, Yuyi Wu, Leilei Wu, Qinglin Wu, Yixuan Wu, Bin Wu, Tianqi Wu, Shiya Wu, Hui-Chen Wu, Jian Wu, Sijun Wu, Yiwen Wu, Cong Wu, Feng Wu, Xi-Ze Wu, Qiuji Wu, Alexander T H Wu, Semon Wu, Qinan Wu, Lai Man Natalie Wu, Zhuokai Wu, Ran Wu, Panyun Wu, Kui Wu, Yumei Wu, Xinrui Wu, Yueling Wu, Biwei Wu, Xing Wu, Hua Wu, Jiayi Wu, Yuen-Jung Wu, Bingjie Wu, Xiaoliang Wu, Matthew A Wu, Jin Wu, Juanjuan Wu, Qiuhong Wu, Hongfu Wu, Xiaoming Wu, Ming-Sian Wu, Ronghua Wu, Junduo Wu, Dandan Wu, Ming-Shiang Wu, Yuliang Wu, Ying-Ying Wu, Chaoling Wu, Guang-Liang Wu, De Wu, Yihua Wu, Yuanyuan Wu, Tsung-Jui Wu, Han Wu, Yulian Wu, Lipeng Wu, Zhihao Wu, Jiexi Wu, Anna H Wu, Qiu Wu, Huazhen Wu, Yaqin Wu, Shengru Wu, Chieh-Lin Stanley Wu, Xiaoqian Wu, Xiahui Wu, Jianli Wu, Yun-Wen Wu, Jian-Yi Wu, Qiuya Wu, Tsai-Kun Wu, Xinyin Wu, Guoyao Wu, Zhenfeng Wu, Guoli Wu, J W Wu, Bill X Wu, Zujun Wu, Jianliang Wu, Yuanshun Wu, Ling-Ying Wu, Zeng-An Wu, Jianrong Wu, Xue Wu, Ke Wu, Mengxue Wu, Cheng-Yang Wu, Jinghong Wu, Rongrong Wu, Ruolan Wu, Rong Wu, Kevin Zl Wu, Xiaohong Wu, Run Wu, Zaihao Wu, Yu-Ke Wu, Chaowei Wu, Xinjing Wu, Anyue Wu, Xuan Wu, Wanxia Wu, Yun Wu, Meili Wu, Shu Wu, Yi-No Wu, Chao-Liang Wu, Chengwei Wu, Y-W Wu, Pensee Wu, Zhao-Bo Wu, Guangxian Wu, Xiao Wu, Juanli Wu, Xinlei Wu, Sai Wu, Changjie Wu, Jiawei Wu, Yujuan Wu, Haoze Wu, Renlv Wu, Yipeng Wu, Xiaoyang Wu, Yuh-Lin Wu, Yu'e Wu, An-Hua Wu, Dan-Chun Wu, Meng-Chao Wu, Yuanhao Wu, Jer-Yuarn Wu, Qian-Yan Wu, Guangyan Wu, Huisheng Wu, Shuting Wu, Huijuan Wu, Long-Jun Wu, Alice Ying-Jung Wu, Xiru Wu, Zhenfang Wu, Lidi Wu, Yetong Wu, Disheng Wu, Linmei Wu, Huiwen Wu, Zhenzhou Wu, Yuhong Wu, Liang Wu, Liyan Wu, Kuan-Li Wu, Pei-Ting Wu, Xiao-Jin Wu, Lifeng Wu, Terence Wu, Shujuan Wu, Gang Wu, Xue-Mei Wu, Szu-Hsien Wu, Yan-ling Wu, Xiaokang Wu, Lingyan Wu, Yih-Jer Wu, Xinghua Wu, Chunfu Wu, Yingxia Wu, Rongling Wu, Xifeng Wu, Jinhua Wu, Sihan Wu, Ming-Yue Wu, Shiyang Wu, K D Wu, Jinmei Wu, Luyan Wu, Shin-Long Wu, Zhipeng Wu, Shuai Wu, Guangzhen Wu, Zhixiang Wu, Longting Wu, Zhengsheng Wu, Xiaoqiong Wu, Yaoxing Wu, Yuqin Wu, Yudan Wu, Zoe Wu, Hongting Wu, Chi-Jen Wu, R Wu, Zhongqiu Wu, Meina Wu, Dengying Wu, Anke Wu, Cheng-Jang Wu, Hsi-Chin Wu, Shufang Wu, Yongjiang Wu, Yuan-de Wu, Sihui Wu, Qi Wu, Wenhui Wu, Fenfang Wu, K S Wu, Nana Wu, Jianzhi Wu, Lin-Han Wu, Zhen Wu, Jinjun Wu, Chen-Lu Wu, Jing-Fang Wu, Haiyan Wu, Yihui Wu, Qiqing Wu, Zhengzhi Wu, Dai-Chao Wu, Zhenyan Wu, Wen-Jeng Wu, Yongqun Wu, Sean M Wu, Guanming Wu, Hei-Man Wu, Su-Hui Wu, Diana H Wu, Ben J Wu, Pingxian Wu, Chew-Wun Wu, Yillin Wu, Xiaobing Wu, Jiang-Bo Wu, Jerry Wu, Siming Wu, Zijun Wu, Daqing Wu, Yu-Hsuan Wu, Lichao Wu, Zhimin Wu, Qijing Wu, Daxian Wu, Zhaoyi Wu, Z Wu, Tong Wu, Cheng-Chun Wu, Tracy Wu, Shusheng Wu, D Wu, Ting-Ting Wu, Xiao-Yan Wu, J Wu, Lan Wu, Changchen Wu, Qi-Fang Wu, Changwei Wu, Liangyan Wu, Liufeng Wu, Kan Wu, Eugenia Wu, Mingming Wu, Xiaolong Wu, Chunru Wu, Zhaofei Wu, Shenhao Wu, Li-Peng Wu, Yuna Wu, Minna Wu, Justin Che-Yuen Wu, Buling Wu, Chengyu Wu, Wutian Wu, Yuwei Wu, Guixin Wu, Haijing Wu, Hei Man Wu, Qiuchen Wu, Xiao-Hui Wu, Junfei Wu, Xiaofeng Wu, Linyu Wu, Wenda Wu, Yung-Fu Wu, Mengbo Wu, Zhenling Wu, Zuping Wu, Maoqing Wu, Julian Wu, Chun-Chieh Wu, Binbin Wu, Xiaohui Wu, Qian Wu, Xinchun Wu, Shuisheng Wu, Linxiang Wu, Xueqing Wu, Bo Wu, Moxin Wu, Xiao-Cheng Wu, Anzhou Wu, Shuyi Wu, Jiahui Wu, Meiqin Wu, Shihao Wu, Jer-Yuan Wu, Wen-Shu Wu, Wudelehu Wu, Ruonan Wu, Song Wu, De-Fu Wu, Yulin Wu, Yurong Wu, Hongyu Wu, Zixuan Wu, Shih-Ying Wu, Chih-Hsing Wu, Chengrong Wu, Yinghao Wu, Yuanzhao Wu, Baochuan Wu, Wenjie Wu, Ziliang Wu, Liuting Wu, Chia-Ling Wu, Y Q Wu, Man Wu, Na Wu, Wutain Wu, Chenyang Wu, Jinyu Wu, Selwin K Wu, Ping Wu, Lorna Wu, D I Wu, Yi-Cheng Wu, Jianzhong Wu, Xiaoyun Wu, Zhourui Wu, Li-Jun Wu, Xinhe Wu, Zhi-Wei Wu, Yinan Wu, Xinyan Wu, Xin Wu, Ting-Feng Wu, Yawei Wu, Shixin Wu, Yiqun Wu, Hong-Mei Wu, Xiaojin Wu, Tsung-Teh Wu, Jiarui Wu, Qi-Nian Wu, Ju Wu, Kai-Yue Wu, Pengjie Wu, Xi-Chen Wu, Zhe Wu, Shaoping Wu, Han-Jie Wu, Zhou Wu, Haijiang Wu, Weijie Wu, Hongfei Wu, Xiaojie Wu, Yi-Ying Wu, Zhentian Wu, Ze Wu, Kai-Hong Wu, Yuting Wu, Minyao Wu, Xueyan Wu, Feifei Wu, Shinan Wu, Yonghui Wu, Haoxuan Wu, Yanzhi Wu, Yiyi Wu, Dong Wu, Guohao Wu, Wenjing Wu, Shibo Wu, Wenqian Wu, Tian Wu, Hai-Yan Wu, Tiantian Wu, Chong Wu, Hongxian Wu, Daoyuan Wu, Zongfu Wu, Ling Wu, Yuxiang Wu, Xilong Wu, Yuyu Wu, Huijian Wu, Zong-Jia Wu, Fengming Wu, Guorong Wu, Chuanhong Wu, Choufei Wu, Chi-Chung Wu, Junfang Wu, Xingwei Wu, Ling-Fei Wu, Xiaoqing Wu, Xinyang Wu, Xiaomin Wu, Yili Wu, Hong-Fu Wu, Shao-Ming Wu, Thomas D Wu, Lizhen Wu, Yuanming Wu, Hsien-Ming Wu, Jian Hui Wu, Litong Wu, Yuxian Wu, Weihua Wu, Lei Wu, C Wu, Wei Wu, Yu-E Wu, Qiulian Wu, Yuexiu Wu, Mei-Hwan Wu, Shaoze Wu, Zilong Wu, Chi-Hao Wu, Baojin Wu, Chao Wu, Yao Wu, Ya Wu, Do-Bo Wu, Wenjun Wu, Zhongren Wu, Nini Wu, Michael C Wu, Ning Wu, Jie Wu, Ming J Wu, Yi-Syuan Wu, Limei Wu, Zhenzhen Wu, Tianwen Wu, Wen-Chieh Wu, Yunhua Wu, Junfeng Wu, Shunan Wu, Junqi Wu, Jianing Wu, Honglin Wu, Maureen Wu, Yexiang Wu, Yan-Hua Wu, Mengjun Wu, Y H Wu, Mingxing Wu, Liuying Wu, Suhua Wu, Xiaomeng Wu, Shyh-Jong Wu, Tung-Ho Wu, Hongliang Wu, Wenxian Wu, Ed Xuekui Wu, Xuekun Wu, Wenqiang Wu, Chuang Wu, Jingyi Wu, Duojiao Wu, Xueyuan Wu, Ji-Zhou Wu, Lianqian Wu, Gaige Wu, Qing-Qian Wu, Haihu Wu, Xiushan Wu, Xueyao Wu, Tingchun Wu, Yafei Wu, Lingxi Wu, R-J Wu, Weidong Wu, Re-Wen Wu, Zhidan Wu, Peiyao Wu, Xuemei Wu, Chen Wu, Yiting Wu, Kerui Wu, Lihong Wu, Shiqi Wu, Liren Wu, Xiuhua Wu, Beili Wu, Yongqi Wu, Ruihong Wu, Huini Wu, Lingyun Wu, Guang-Long Wu, Po-Chang Wu, Wenxue Wu, Qinghua Wu, Ru-Zi Wu, Wenlin Wu, Changjing Wu, Xiexing Wu, J Y Wu, Jianping Wu, Guanggeng Wu, W J Wu, Zhichong Wu, Di Wu, Shaoyu Wu, Xiaotong Wu, Junyong Wu, Hui Wu, Hongyan Wu, Shengde Wu, Mengyuan Wu, Yutong Wu, Zheming Wu, Yiping Wu, Dapeng Wu, Guiping Wu, Wen-Hui Wu, Bing Wu, Wen-Sheng Wu, Yunpeng Wu, Li-Ling Wu, Xiao-Yuan Wu, Baiyan Wu, Qiu-Li Wu, Xiao-Ye Wu, Ying Wu, Da-Hua Wu, Hsing-Chieh Wu, Hui-Xuan Wu, Chieh-Jen Wu, Pengning Wu, Sichen Wu, S F Wu, Mengying Wu, Jia-En Wu, Ming-Der Wu, Qi-Jun Wu, Weida Wu, Guo-Chao Wu, Zhenyong Wu, Qi-Biao Wu, Yangfeng Wu, Lijie Wu, Zhiye Wu, Jihui Wu, Qianqian Wu, Zhengliang L Wu, JieQian Wu, Jingyun Wu, Xiaoman Wu, Ruohao Wu, Yiyang Wu, Zhengfeng Wu, Xiao-Jun Wu, Lizi Wu, Qiang Wu, J-Z Wu, Guangjie Wu, Pengfei Wu, Jundong Wu, Beier Wu, Jianying Wu, Meng-Ling Wu, Lingxiang Wu, Jamie L Y Wu, Keija Wu, Xilin Wu, Yanhua Wu, An-Li Wu, Yi-Ming Wu, Chengbiao Wu, Huanghui Wu, Dong-Feng Wu, Kunsheng Wu, Zhengcan Wu, Yuxin Wu, Kun-Rong Wu, Dong-Fang Wu, Guanxian Wu, Guifen Wu, Sensen Wu, Yifeng Wu, Pin Wu, Tzu-Chun Wu, Qingping Wu, R M Wu, Mian Wu, S J Wu, Senquan Wu, Haisu Wu, Jingjing Wu, Cheng Wu, Meng Wu, Geping Wu, Yu Wu, Yumin Wu, Xia Wu, William Ka Kei Wu, Xian-Run Wu, Juan Wu, Pei-Ei Wu, Meng-Hsun Wu, Yingying Wu, S M Wu, Xiangwei Wu, Guangrun Wu, Liuxin Wu, Yangyu Wu, Jia-Hui Wu, Jin-Zhen Wu, Shaohuan Wu, S L Wu, June K Wu, Yanli Wu, Haishan Wu, H Wu, Zhou-Ming Wu, Deqing Wu, Tao Wu, Dong-Bo Wu, Binxin Wu, Yalan Wu, Xiangxin Wu, Xueji Wu, Hongxi Wu, Zhonghui Wu, Jiaxi Wu, Tianzhi Wu, Meiqi Wu, Yan-Jun Wu, Weiwei Wu, Lijuan Wu, Tingqin Wu, Jianming Wu, P L Wu, Yih-Ru Wu, Lanlan Wu, Jianjun Wu, An-Xin Wu, Jianguang Wu, Xingjie Wu, Jianzhang Wu, Xianan Wu, Wei-Ping Wu, Haoan Wu, Fang-Tzu Wu, Wenwen Wu, Zhongjun Wu, Xi Wu, Teng Wu, Xiaoling Wu, Mengjuan Wu, Wen Wu, Yifan Wu, Yang Wu, Qianhu Wu, Wu-Tian Wu, Shenyue Wu, Qianwen Wu, Ye Wu, Lixing Wu, Gui-Qin Wu, Grace F Wu, Xing-Ping Wu, Ming Wu, Lisha Wu, Yanchuan Wu, Siqi Wu, Yuming Wu, Yuan Wu, Yu-Ting Wu, I H Wu, Hailong Wu, Minghua Wu, B Wu, Zhenlong Wu, Fang Wu, Guanzhong Wu, Liqun Wu, Guifu Wu, Chris Y Wu, Zhikang Wu, Qi-Yong Wu, Qingshi Wu, Zhao-Yang Wu, Chih-Ching Wu, Man-Jing Wu, Jun Wu, Jinhui Wu, Jincheng Wu, Linhong Wu, Hung-Tsung Wu, Tangchun Wu, Xinglong Wu, Zhen-Yang Wu, Ma Wu, Jiu-Lin Wu, Dongyan Wu, Yin Wu, Yong Wu, Yan Wu, Weizhen Wu, Changyu Wu, Fanggeng Wu, Dishan Wu, Yue Wu, Ge-ru Wu, Yi-Long Wu, Jinqiao Wu, Jing-Wen Wu, Zhongyang Wu, Lifang Wu, Songfen Wu, Sheng-Li Wu, Jia-Wei Wu, Yihan Wu, Kebang Wu, Wenyong Wu, Cai-Qin Wu, Yilong Wu, Yanan Wu, Hsiu-Chuan Wu, Xueqian Wu, Paul W Wu, Yen-Wen Wu, Xing-De Wu, Ying-Ting Wu, Yucan Wu, Mingfu Wu, Na-Qiong Wu, Linzhi Wu, Jinze Wu, Xuhan Wu, H J Wu, Dirong Wu, Ruize Wu, Chung-Yi Wu, Yaohong Wu, Jianyi Wu, Jugang Wu, Jiao Wu, Liang-Huan Wu, Xueling Wu, Ruying Wu, Gen Sheng Wu, Zhaoyuan Wu, Shiwen Wu, Andong Wu, Yu-Ling Wu, Hsan-Au Wu, Jia-Qi Wu, Yanting Wu, Xihai Wu, Lulu Wu, Xuxian Wu, Xiaomei Wu, Jingyue Wu, Shuihua Wu, Ren Wu, S Wu, Yupeng Wu, Haoming Wu, Samuel M Wu, Fan Wu, Yuesheng Wu, Yihe Wu, Tiange Wu, Chia-Lung Wu, Shuang Wu, Jiayu Wu, Shengnan Wu, Yaojiong Wu, Zhuoze Wu, Y Y Wu, Y Wu, Zimu Wu, Depei Wu, Yi-Hua Wu, Yanyan Wu, Haiyun Wu, Min Wu, Wenjuan Wu, Jinfeng Wu, Guangxi Wu, Junjie Wu, Yawen Wu, Pinglian Wu, Hui-Hui Wu, Xunwei Wu, Xuefeng Wu, Constance Wu, Depeng Wu, Dianqing Wu, Qibiao Wu, Hao-Tian Wu, Nan Wu, Hanyu Wu, Xiaojiang Wu, Cheng-Jun Wu, San-pin Wu, Xiaofan Wu, Xiwei Wu, Shi-Xin Wu, Shao-Guo Wu, Sunyi Wu, Yueheng Wu, Chengqian Wu, Kuixian Wu, Xin-Xi Wu, Guanyi Wu, Qiuxia Wu, Danhong Wu, He Wu, Zhong-Jun Wu, Siyi Wu, Xiangsheng Wu, Lanxiang Wu, Kaili Wu, Liting Wu, Ping-Hsun Wu, Zheng Wu, Wen-Ling Wu, Jiang-Nan Wu, Huanlin Wu, Yongfei Wu, Catherine A Wu, Leslie Wu, Shuo Wu, Peng-Fei Wu, Meng-Han Wu, Cho-Kai Wu, Hon-Yen Wu, Anguo Wu, Yuguang Philip Wu, Hai-Yin Wu, Yicheng Wu, Xiaolang Wu, Yujie Wu, Qing Wu, Haomin Wu, V C Wu, Xingdong Wu, Hengyu Wu, Jiang Wu, Chengxi Wu, Xiaoli Wu, Junyi Wu, Ling-qian Wu, William K K Wu, Chun Wu, Lesley Wu, Niting Wu, Jiayuan Wu, Xueying Wu, Yingning Wu, S-F Wu, David Wu, Mei-Na Wu, Joshua L Wu, Jin-Shang Wu, Guanzhao Wu, Jianqiang Wu, Runda Wu, Li-Hsien Wu, June-Hsieh Wu, Rongjie Wu, Huazhang Wu, Huanwen Wu, Xiu-Zhi Wu, Yanran Wu, Xianfeng Wu, Weibin Wu, Xuanshuang Wu, Yan Yan Wu, G X Wu, Runpei Wu, Jiaqi Wu, Chien-Ting Wu, Li-Na Wu, Qinfeng Wu, Chia-Chang Wu, Yueming Wu, Renhai Wu, Siyu Wu, Baojian Wu, Yi-Xia Wu, Renrong Wu, Wei-Yin Wu, C-H Wu, Chuan-Ling Wu, Xinran Wu, Fengying Wu, Qiuliang Wu, Guanhui Wu, Jinjie Wu, Wei-Chi Wu, Wei-Xun Wu, Meng-Na Wu, Lin Wu, Wan-Fu Wu, Jiajing Wu, Colin Chih-Chien Wu, Yajie Wu, Yaru Wu, Qiaowei Wu, Xiaoping Wu, Xue-Yan Wu, Weijun Wu, Mengchao Wu, Boquan Wu, Chunyan Wu, Zelai Wu, Pei-Wen Wu, Guojun Wu, Yichen Wu, Ming-Tao Wu, Hsueh-Erh Wu, Guang-Bo Wu, Zhi-Yong Wu, Chia-Zhen Wu, Kay L H Wu, Yong-Hong Wu, Anping Wu, Jiahang Wu, Xiaobin Wu, Ching-Yi Wu, Linzhen Wu, Xiaoxing Wu, Haidong Wu, Zhen-Qi Wu, Mark N Wu, Jianmin Wu, Guanrong Wu, Xianpei Wu, Yanchun Wu, Dongsheng Wu, An-Dong Wu, Ren-Chin Wu, Yuchen Wu, Mengna Wu, Lijun Wu, Zhuanbin Wu, Yanjing Wu, Haodi Wu, Lun Wu, Si-Jia Wu, Yongfa Wu, Ximei Wu, Hai-Ping Wu, Wenyu Wu, Xiangping Wu, L-F Wu, Yixia Wu, Yiran Wu, Haiying Wu, Yanhong Wu, Xiayin Wu, Yushun Wu, Yali Wu, Qitian Wu, Qin Wu, Xiaofu Wu, Jiamei Wu, Xiaoyong Wu, Qiong Wu, Xiaoying Wu, Wujun Wu, N Wu, Peiyi Wu, Yongmei Wu, Xiaojing Wu, Yizhou Wu, Dan Wu, Wen-Qiang Wu, Junqing Wu, Anshi Wu, Xiao-Yang Wu, Zhaoxia Wu, Liyang Wu, Hongke Wu, Mengqiu Wu, Ding Lan Wu, Peng Wu, Haibin Wu, Lecheng Wu, Yingzhi Wu, Kejia Wu, Anyi Wu, Junshu Wu, Jianxin Wu, Deguang Wu, Jiaxuan Wu, Justin C Y Wu, W Wu, Jiong Wu, Yu-Chih Wu, Qinglan Wu, Xinyi Wu, Diana Wu, Xuefen Wu, Zhongluan Wu, Yanqiong Wu, Shengming Wu, Jian-Lin Wu, Daren Wu, Donglin Wu, Lintao Wu, Xiaodong Wu, Chang-Jiun Wu, Chunshuai Wu, Irene X Y Wu, Yaping Wu, Xiping Wu, Yangna Wu, Zongheng Wu, Chia-Chen Wu, Wenyi Wu, Yansheng Wu, Shaojun Wu, Aimin Wu, Caisheng Wu, Xu Wu, Zhongchan Wu, Fei Wu, Yaohua Wu, Qinyi Wu, Yibo Wu, Zhengyu Wu, Yadi Wu, Hang Wu, L Wu, Mingjun Wu, Yuetong Wu, Wen-Juan Wu, Guangming Wu, Lingzhi Wu, Tingting Wu, Zhong-Yan Wu, Zhuzhu Wu, Yuanbing Wu, Cuiyan Wu, Baoqin Wu, Colin O Wu, Shuyan Wu, Hongmei Wu, Guangsen Wu, Xiaolin Wu, An Guo Wu, Kailang Wu, Chien-Sheng Wu, Chun-Hua Wu, Jemma X Wu, Wenqi Wu, Quanhui Wu, Qing-Wu Wu, Yanxiang Wu, Jiajin Wu, Yuan Kai Wu, Qiao Wu
articles
Sen Guo, Jing Zhou, Liang Zhang +6 more · 2022 · Chinese journal of integrative medicine · Springer · added 2026-04-24
To explore whether acupuncture combined with moxibustion could inhibit epithelialmesenchymal transition in Crohn's disease by affecting the transforming growth factor β 1 (TGF- β 1)/Smad3/Snail pathwa Show more
To explore whether acupuncture combined with moxibustion could inhibit epithelialmesenchymal transition in Crohn's disease by affecting the transforming growth factor β 1 (TGF- β 1)/Smad3/Snail pathway. Sixty-three patients with Crohn's disease were randomly divided into an observation group (31 cases) receiving moxibustion at 43 °C combined with acupuncture, and a control group (32 cases) receiving moxibustion at 37 °C combined with sham acupuncture using a random number table. Patients were treated for 12 weeks. Crohn's Disease Activity Index (CDAI) was used to evaluate disease activity. Hematoxylin-eosin staining and transmission electron microscopy were utilized to observe the morphological and ultrastructural changes. Immunohistochemistry was used to detect the expression of transforming growth factor β 1 (TGF-β 1), T β R1, T β R2, Smad3, Snail, E-cadherin and fibronectin in intestinal mucosal tissues. The decrease of the CDAI score, morphological and ultrastructural changes were more significant in observation group. The expression levels of TGF- β 1, Tβ R2, Smad3, and Snail in the observation group were significantly lower than those before the treatment (P<0.05 or P<0.01). After treatment, the expression levels of TGF-β 1, TβR2, and Snail in the observation group were significantly lower than those in the control group (all P<0.05); compared with the control group, the expression of fibronectin in the observation group was significantly decreased, and the expression of E-cadherin was significantly increased (all P<0.05). Moxibustion at 43 °C combined with acupuncture may suppress TGF-β 1/Smad3/Snail pathway-mediated epithelial-mesenchymal transition of intestinal epithelial cells in Crohn's disease patients by inhibiting the expression levels of TGF-β 1, Tβ R2, Smad3, and Snail. (Registration No. ChiCTR-IIR-16007751). Show less
no PDF DOI: 10.1007/s11655-022-2888-1
SNAI1
Runze Wang, Cuixiu Peng, Junying Song +8 more · 2022 · International journal of oncology · added 2026-04-24
Regulator of ribosome synthesis 1 (RRS1) is a key factor in ribosome biosynthesis and other cellular functions. High level of RRS1 in breast cancer cell lines is associated with increased cell prolife Show more
Regulator of ribosome synthesis 1 (RRS1) is a key factor in ribosome biosynthesis and other cellular functions. High level of RRS1 in breast cancer cell lines is associated with increased cell proliferation, invasion and migration. RRS1 controls the assembly of the 60s subunit and maturation of 25S rRNA during ribosome biosynthesis. In this study, lentiviral transfection of sh‑RNA was used to knock down the level of RRS1, to detect the effect of RRS1 on cell function and to explore the specific mechanism of RRS1 affecting cell invasion and metastasis by COIP and dual‑luciferase reporter gene assays. The present study found that RRS1 knockdown reduced the accumulation of ribosome protein L11 (RPL11) in the nucleolus, which then migrated to the nucleoplasm and bound to c‑Myc. This inhibited trans‑activation of SNAIL by c‑Myc and eventually decreased the invasion and metastasis capacity of the human breast cancer cell line BT549. Taken together, RRS1 regulates invasion and metastasis of human breast cancer cells through the RPL11‑c‑Myc‑SNAIL axis. The findings are of great significance for exploring the mechanism of breast cancer invasion and metastasis and the corresponding regulatory factors. Show less
no PDF DOI: 10.3892/ijo.2022.5323
SNAI1
Wei Xie, Qiwei Jiang, Xueji Wu +9 more · 2022 · Cell death and differentiation · Nature · added 2026-04-24
IKBKE, a non-canonical inflammatory kinase, is frequently amplified or activated, and plays predominantly oncogenic roles in human cancers, especially in breast cancer. However, the potential function Show more
IKBKE, a non-canonical inflammatory kinase, is frequently amplified or activated, and plays predominantly oncogenic roles in human cancers, especially in breast cancer. However, the potential function and underlying mechanism of IKBKE contributing to breast cancer metastasis remain largely elusive. Here, we report that depletion of Ikbke markedly decreases polyoma virus middle T antigen (PyVMT)-induced mouse mammary tumorigenesis and subsequent lung metastasis. Biologically, ectopic expression of IKBKE accelerates, whereas depletion of IKBKE attenuates breast cancer invasiveness and migration in vitro and tumor metastasis in vivo. Mechanistically, IKBKE tightly controls the stability of transcriptional factor Snail in different layers, in particular by directly phosphorylating Snail, which markedly blocks the E3 ligase β-TRCP1-mediated Snail degradation, resulting in breast cancer epithelial-mesenchymal transition (EMT) and metastasis. These findings together reveal a novel oncogenic function of IKBKE in promoting breast cancer metastasis by governing Snail abundance, and highlight the potential of targeting IKBKE for metastatic breast cancer therapies. Show less
no PDF DOI: 10.1038/s41418-022-00940-1
SNAI1
Qiong Li, Jing-Xian Chen, Yuan Wu +8 more · 2022 · Journal of ethnopharmacology · Elsevier · added 2026-04-24
Fuzheng Xiaojijinzhan (FZXJJZF) decoction is an effective prescription for treating colorectal cancer liver metastasis (LMCRC). To elucidate the pharmacological mechanism of the FZXJJZF decoction ther Show more
Fuzheng Xiaojijinzhan (FZXJJZF) decoction is an effective prescription for treating colorectal cancer liver metastasis (LMCRC). To elucidate the pharmacological mechanism of the FZXJJZF decoction therapy on LMCRC. Firstly, a network pharmacological approach was used to characterize the underlying targets of FZXJJZF on LMCRC. Secondly, LMCRC-related genes are obtained from the public database TCGA, and those genes are further screened and clustered through Mfuzz, an R package tool. Then, targets of FZXJJZF predicted by network pharmacology were overlapped with LMCRC related genes screened by Mfuzz. Meanwhile, FZJZXJF intervened in LMCRC model,epithelial-to-mesenchymal transition (EMT), and migration and invasion of HCT-116 cells. Thirdly, the transcriptomics data of FZJZXJF inhibited HCT-116 cells of EMT cells were overlapped with EMT database data to narrow the possible range of targets. Based on this, the potential targets and signal pathways of FZJZXJF were speculated by combining the transcriptomics data with the targets from network pharmacology-TCGA. Finally, the anti-cancer mechanism of FZXJJZF on LMCRC was verified in vitro by Real-Time PCR and Western Blot in vitro. By network pharmacological analysis, 282 ingredients and 429 potential targets of FZXJJZF were predicted. The 9268 LMCRC-related genes in the TCGA database were classified into 10 clusters by the Mfuzz. The two clustering genes with the most similar clustering trends were overlapped with 429 potential targets, and 32 genes were found, such as CD34, TRPV3, PGR, VDR, etc. In vivo experiments, FZJZXJF inhibited the tumor size in LMCRC models, and the EMT, migration, and invasion of HCT-116 also be inhibited. Intersecting transcriptomics dates with 32 target genes, it is speculated that the VDR-TGF-β signaling pathway may be an effective mechanism of FZXJJZF. Additionally, it is shown that FZXJJZF up-regulated the expression levels of VDR and E-cadherin and down-regulated the expression levels of TGF-β and Snail1 in vitro. These results confirmed that FZXJJZF plays an effective role in LMCRC mainly by inhibiting EMT phenotype via the VDR-TGF-β signaling pathway. Collectively, this study reveals the anti-LMCRC effect of FZXJJZF and its potential therapeutic mechanism from the perspective of potential targets and potential pathways. Show less
no PDF DOI: 10.1016/j.jep.2021.114904
SNAI1
Chunfan Huang, Xiaoqi Jing, Qianhu Wu +1 more · 2022 · Carbohydrate polymers · Elsevier · added 2026-04-24
Renal fibrosis is the final common result of a variety of progressive injuries leading to chronic renal failure. However, there are no effective clinical available drugs for the treatment. Notoginseno Show more
Renal fibrosis is the final common result of a variety of progressive injuries leading to chronic renal failure. However, there are no effective clinical available drugs for the treatment. Notoginsenoside from Panax notoginseng could ameliorate renal fibrosis. We hypothesized that polysaccharide from this herb might have similar bioactivity. Here, we elucidated structure of a novel pectin-like polysaccharide designed SQD4S2 with a netty antenna backbone of glucogalacturonan substituted by glucoarabinan, glucurogalactan and galactose residues from this herb. Interestingly, SQD4S2 could reverse the morphological changes of human renal tubular HK-2 cells induced by TGF-β. Mechanism study suggested that this bioactivity might associate with N-cadherin (CDH2), Snail (SNAI1), Slug (SNAI2) depression and E-cadherin (CDH1) enhancement. In addition, SQD4S2 could impede critical fibrogenesis associated molecules such as α-SMA, fibronectin, vimentin, COL1A1, COL3A1, FN1 and ACTA2 expression induced by TGF-β in HK-2 cells. Current findings outline a novel leading polysaccharide for against renal fibrosis new drug development. Show less
no PDF DOI: 10.1016/j.carbpol.2021.118772
SNAI1
Yongjie Wang, Yanyan Wu, Shilei Zhang · 2022 · BMC veterinary research · BioMed Central · added 2026-04-24
Bisphenol-A (BPA) has estrogenic activity and adversely affects humans and animals' reproductive systems and functions. There has been a disagreement with the safety of BPA exposure at Tolerable daily Show more
Bisphenol-A (BPA) has estrogenic activity and adversely affects humans and animals' reproductive systems and functions. There has been a disagreement with the safety of BPA exposure at Tolerable daily intake (TDI) (0.05 mg/kg/d) value and non-observed adverse effect level (5 mg/kg/d). The current study investigated the effects of BPA exposure at various doses starting from Tolerable daily intake (0.05 mg/kg/d) to the lowest observed adverse effect level (50 mg/kg/d) on the testis development in male mice offspring. The BPA exposure lasted for 63 days from pregnancy day 0 of the dams to post-natal day (PND) 45 of the offspring. The results showed that BPA exposure significantly increased testis (BPA ≥ 20 mg/kg/d) and serum (BPA ≥ 10 mg/kg/d) BPA contents of PND 45 mice. The spermatogenic cells became loose, and the lumen of seminiferous tubules enlarged when BPA exposure at 0.05 mg/kg/d TDI. BPA exposure at a low dose (0.05 mg/kg/d) significantly reduced the expression of Scp3 proteins and elevated sperm abnormality. The significant decrease in Scp3 suggested that BPA inhibits the transformation of spermatogonia into spermatozoa in the testis. The RNA-seq proved that the spliceosome was significantly inhibited in the testes of mice exposed to BPA. According to the RT-qPCR, BPA exposure significantly reduced the expression of Snrpc (BPA ≥ 20 mg/kg/d) and Hnrnpu (BPA ≥ 0.5 mg/kg/d). This study indicated that long-term BPA exposure at Tolerable daily intake (0.05 mg/kg/d) is not safe because low-dose long-term exposure to BPA inhibits spermatogonial meiosis in mice testis impairs reproductive function in male offspring. Show less
no PDF DOI: 10.1186/s12917-022-03336-y
SNRPC
Lunni Zhou, Haobin Liu, Qingqing Zhao +2 more · 2022 · Cell discovery · Nature · added 2026-04-24
NALCN regulates the resting membrane potential by mediating the Na
no PDF DOI: 10.1038/s41421-022-00392-4
UNC79
Andrés Guillén-Samander, Yumei Wu, S Sebastian Pineda +7 more · 2022 · Proceedings of the National Academy of Sciences of the United States of America · National Academy of Sciences · added 2026-04-24
Chorea-acanthocytosis (ChAc) and McLeod syndrome are diseases with shared clinical manifestations caused by mutations in VPS13A and XK, respectively. Key features of these conditions are the degenerat Show more
Chorea-acanthocytosis (ChAc) and McLeod syndrome are diseases with shared clinical manifestations caused by mutations in VPS13A and XK, respectively. Key features of these conditions are the degeneration of caudate neurons and the presence of abnormally shaped erythrocytes. XK belongs to a family of plasma membrane (PM) lipid scramblases whose action results in exposure of PtdSer at the cell surface. VPS13A is an endoplasmic reticulum (ER)-anchored lipid transfer protein with a putative role in the transport of lipids at contacts of the ER with other membranes. Recently VPS13A and XK were reported to interact by still unknown mechanisms. So far, however, there is no evidence for a colocalization of the two proteins at contacts of the ER with the PM, where XK resides, as VPS13A was shown to be localized at contacts between the ER and either mitochondria or lipid droplets. Here we show that VPS13A can also localize at ER-PM contacts via the binding of its PH domain to a cytosolic loop of XK, that such interaction is regulated by an intramolecular interaction within XK, and that both VPS13A and XK are highly expressed in the caudate neurons. Binding of the PH domain of VPS13A to XK is competitive with its binding to intracellular membranes that mediate other tethering functions of VPS13A. Our findings support a model according to which VPS13A-dependent lipid transfer between the ER and the PM is coupled to lipid scrambling within the PM. They raise the possibility that defective cell surface exposure of PtdSer may be responsible for neurodegeneration. Show less
no PDF DOI: 10.1073/pnas.2205425119
VPS13C
Shujun Cai, Yumei Wu, Andrés Guillén-Samander +3 more · 2022 · Proceedings of the National Academy of Sciences of the United States of America · National Academy of Sciences · added 2026-04-24
VPS13 is a eukaryotic lipid transport protein localized at membrane contact sites. Previous studies suggested that it may transfer lipids between adjacent bilayers by a bridge-like mechanism. Direct e Show more
VPS13 is a eukaryotic lipid transport protein localized at membrane contact sites. Previous studies suggested that it may transfer lipids between adjacent bilayers by a bridge-like mechanism. Direct evidence for this hypothesis from a full-length structure and from electron microscopy (EM) studies in situ is still missing, however. Here, we have capitalized on AlphaFold predictions to complement the structural information already available about VPS13 and to generate a full-length model of human VPS13C, the Parkinson's disease-linked VPS13 paralog localized at contacts between the endoplasmic reticulum (ER) and endo/lysosomes. Such a model predicts an ∼30-nm rod with a hydrophobic groove that extends throughout its length. We further investigated whether such a structure can be observed in situ at ER-endo/lysosome contacts. To this aim, we combined genetic approaches with cryo-focused ion beam (cryo-FIB) milling and cryo-electron tomography (cryo-ET) to examine HeLa cells overexpressing this protein (either full length or with an internal truncation) along with VAP, its anchoring binding partner at the ER. Using these methods, we identified rod-like densities that span the space separating the two adjacent membranes and that match the predicted structures of either full-length VPS13C or its shorter truncated mutant, thus providing in situ evidence for a bridge model of VPS13 in lipid transport. Show less
no PDF DOI: 10.1073/pnas.2203769119
VPS13C
William Hancock-Cerutti, Zheng Wu, Peng Xu +6 more · 2022 · The Journal of cell biology · added 2026-04-24
Mutations in VPS13C cause early-onset, autosomal recessive Parkinson's disease (PD). We have established that VPS13C encodes a lipid transfer protein localized to contact sites between the ER and late Show more
Mutations in VPS13C cause early-onset, autosomal recessive Parkinson's disease (PD). We have established that VPS13C encodes a lipid transfer protein localized to contact sites between the ER and late endosomes/lysosomes. In the current study, we demonstrate that depleting VPS13C in HeLa cells causes an accumulation of lysosomes with an altered lipid profile, including an accumulation of di-22:6-BMP, a biomarker of the PD-associated leucine-rich repeat kinase 2 (LRRK2) G2019S mutation. In addition, the DNA-sensing cGAS-STING pathway, which was recently implicated in PD pathogenesis, is activated in these cells. This activation results from a combination of elevated mitochondrial DNA in the cytosol and a defect in the degradation of activated STING, a lysosome-dependent process. These results suggest a link between ER-lysosome lipid transfer and innate immune activation in a model human cell line and place VPS13C in pathways relevant to PD pathogenesis. Show less
no PDF DOI: 10.1083/jcb.202106046
VPS13C
Jing Yan, Lun-Gang Wu, Ming Zhang +4 more · 2022 · Oxidative medicine and cellular longevity · added 2026-04-24
Intervertebral disc degeneration (IDD) development is regulated by miRNA, including inflammatory reactions, cell apoptosis, and degradation of extracellular matrix. Nucleus pulposus cells apoptosis ha Show more
Intervertebral disc degeneration (IDD) development is regulated by miRNA, including inflammatory reactions, cell apoptosis, and degradation of extracellular matrix. Nucleus pulposus cells apoptosis has a absolute influence in the development of IDD. This experiment explores the mechanism of miR-328-5p regulating IDD. Through the analysis of miRNA and mRNA microarray database, we screened the target genes miR-328-5p and WWP2. We verified the expression of miR-328-5p, WWP2, and related apoptotic genes in normal and degenerative nucleus pulposus tissues by qRT-PCR. The expressions of WWP2, Bcl-2, and Bax were detected by qRT-PCR and western blot after transfection to nucleus pulposus cell. The nucleus pulposus cell proliferation and apoptosis after transfection were confirmed by CCK8 and flow cytometry. Luciferase reporter assay and bioinformatics analyzed the targeting relationship between miR-328-5p and WWP2. Firstly, the qRT-PCR experiments confirmed the significant increase of miR-328-5p expression, while significant reduction of WWP2 in a degenerative tissues compared to the normal tissues. Surprisingly, miR-328-5p expression was positively, while that of WWP2 negatively correlated with the degeneration grade of IDD. And we also identified the high expression of Bax and Caspase3, while low expression of Bcl-2 in a degenerative tissues. After miR-328-5p mimic transfected into nucleus pulposus cell, qRT-PCR and western blot confirmed that WWP2 and Bcl-2 expressions were downregulated, while Bax and Caspase3 expressions were upregulated, and the same results were obtained by knocking down WWP2. CCK8 and flow cytometry confirmed that miR-328-5p inhibited the proliferation and induced apoptosis of nucleus pulposus cells. WWP2 is a target gene of miR-328-5p by bioinformatics and luciferase reporter assay. In summary, miR-328-5p targets WWP2 to regulate nucleus pulposus cells apoptosis and then participates in the development of IDD. Furthermore, this study may provide new references and ideas for IDD treatment. Show less
no PDF DOI: 10.1155/2022/3511967
WWP2
Naijin Zhang, Ying Zhang, Wei Miao +12 more · 2022 · Redox biology · Elsevier · added 2026-04-24
Oxidative stress-associated endothelial damage is the initiation factor of cardiovascular disease, and protein posttranslational modifications play critical roles in this process. Bcl-2-associated ath Show more
Oxidative stress-associated endothelial damage is the initiation factor of cardiovascular disease, and protein posttranslational modifications play critical roles in this process. Bcl-2-associated athanogene 3 (BAG3) is a molecular chaperone regulator of the BAG family, which interacts with various proteins and influences cell survival by activating multiple pathways. BAG3 undergoes posttranslational modifications; however, research evaluating BAG3 acetylation and its regulatory mechanism is lacking. In addition, the interacting protein and regulatory mechanism of BAG3 in oxidative stress-associated endothelial damage remain unclear. Here, key molecular interactions and protein modifications of BAG3 were identified in oxidative stress-associated endothelial damage. Endothelial-specific BAG3 knockout in the mouse model starkly enhances oxidative stress-associated endothelial damage and vascular remodeling, while BAG3 overexpression in mice significantly relieves this process. Mechanistically, poly(ADP-ribose) polymerase 1 (PARP1), causing oxidative stress, was identified as a novel physiological substrate of BAG3. Indeed, BAG3 binds to PARP1's BRCT domain to promote its ubiquitination (K249 residue) by enhancing the E3 ubiquitin ligase WWP2, which leads to proteasome-induced PARP1 degradation. Furthermore, we surprisingly found that BAG3 represents a new substrate of the acetyltransferase CREB-binding protein (CBP) and the deacetylase Sirtuin 2 (SIRT2) under physiological conditions. CBP/SIRT2 interacted with BAG3 and acetylated/deacetylated BAG3's K431 residue. Finally, deacetylated BAG3 promoted the ubiquitination of PARP1. This work reveals a novel regulatory system, with deacetylation-dependent regulation of BAG3 promoting PARP1 ubiquitination and degradation via enhancing WWP2, which is one possible mechanism to decrease vulnerability of oxidative stress in endothelial cells. Show less
no PDF DOI: 10.1016/j.redox.2022.102238
WWP2
Wei Gao, Jianhui Zhang, Runda Wu +2 more · 2022 · Frontiers in genetics · Frontiers · added 2026-04-24
no PDF DOI: 10.3389/fgene.2022.855549
ZC3H4
Wei Wang, Jianqiang Wu, Peng Liu +8 more · 2021 · Frontiers in molecular biosciences · Frontiers · added 2026-04-24
📄 PDF DOI: 10.3389/fmolb.2021.714706
ACP2

CD8

Kaiyi Zhang, Cong Tao, Jianping Xu +14 more · 2021 · Frontiers in immunology · Frontiers · added 2026-04-24
Anti-inflammatory therapies have the potential to become an effective treatment for obesity-related diseases. However, the huge gap of immune system between human and rodent leads to limitations of dr Show more
Anti-inflammatory therapies have the potential to become an effective treatment for obesity-related diseases. However, the huge gap of immune system between human and rodent leads to limitations of drug discovery. This work aims at constructing a transgenic pig model with higher risk of metabolic diseases and outlining the immune responses at the early stage of metaflammation by transcriptomic strategy. We used CRISPR/Cas9 techniques to targeted knock-in three humanized disease risk genes, Show less
📄 PDF DOI: 10.3389/fimmu.2021.690069
GIPR
Xiumin Shi, Qing Li, Lulu Zhang +10 more · 2021 · Bioconjugate chemistry · ACS Publications · added 2026-04-24
Targeted radionuclide therapy (TRT) provides new and safe opportunities for cancer treatment and management with high precision and efficiency. Here we have designed a novel semiconducting polymer nan Show more
Targeted radionuclide therapy (TRT) provides new and safe opportunities for cancer treatment and management with high precision and efficiency. Here we have designed a novel semiconducting polymer nanoparticle (SPN)-based radiopharmaceutical ( Show less
no PDF DOI: 10.1021/acs.bioconjchem.1c00263
GIPR
Fenghui Zhao, Chao Zhang, Qingtong Zhou +15 more · 2021 · eLife · added 2026-04-24
Glucose-dependent insulinotropic polypeptide (GIP) is a peptide hormone that exerts crucial metabolic functions by binding and activating its cognate receptor, GIPR. As an important therapeutic target Show more
Glucose-dependent insulinotropic polypeptide (GIP) is a peptide hormone that exerts crucial metabolic functions by binding and activating its cognate receptor, GIPR. As an important therapeutic target, GIPR has been subjected to intensive structural studies without success. Here, we report the cryo-EM structure of the human GIPR in complex with GIP and a G Show less
📄 PDF DOI: 10.7554/eLife.68719
GIPR
Chun Han, Yuqing Sun, Qimeng Yang +5 more · 2021 · Molecular pharmaceutics · ACS Publications · added 2026-04-24
Novel peptidic glucagon receptor (GCGR) and glucagon-like peptide 1 receptor (GLP-1R) dual agonists are reported to have increased efficacy over GLP-1R monoagonists for the treatment of diabetes and o Show more
Novel peptidic glucagon receptor (GCGR) and glucagon-like peptide 1 receptor (GLP-1R) dual agonists are reported to have increased efficacy over GLP-1R monoagonists for the treatment of diabetes and obesity. We identified a novel Show less
no PDF DOI: 10.1021/acs.molpharmaceut.0c00995
GIPR
Long Teng, Tuchen Guan, Beibei Guo +6 more · 2021 · Biochemical and biophysical research communications · Elsevier · added 2026-04-24
The intrinsic capacity of axonal growth is varied among the neurons form different tissues or different developmental stages. In this study, we established an in vitro model to compare the axonal grow Show more
The intrinsic capacity of axonal growth is varied among the neurons form different tissues or different developmental stages. In this study, we established an in vitro model to compare the axonal growth of neurons from embryonic 18 days, post-natal 1 day and post-natal 3 days rat. The E18 neurons showed powerful ability of neuritogenensis and axon outgrowth and the ability decreased rapidly along with development. The transcriptome profile of these neurons revealed a set of genes positively correlated with the capacity of neurite outgrowth. Glucose-dependent insulinotropic polypeptide receptor (GIPR) is identified as a gene to promote neurite outgrowth, which was approved by siRNA knock down assay in E18 neuron. Glucose-dependent insulinotropic polypeptide (GIP), a ligand of GIPR secreted from enteroendocrine K cells, is well-known for its role in nutrient sensing and intake. To verify the effect of GIP-GIPR signal on neurite outgrowth, we administrated GIP to stimulate the E18 neurons, the results showed that GIP significantly improved extension of axon. We further revealed that GIP increased Rac1/Cdc42 phosphorylation in Akt dependent manner. In summary, our study established an in vitro model to screen the genes involved in neurite outgrowth, and we provided mechanical insight on the GIP-GIPR axis to promote axonal outgrowth. Show less
no PDF DOI: 10.1016/j.bbrc.2020.11.120
GIPR
Yong Han, Guobin Xia, Dollada Srisai +11 more · 2021 · Nature communications · Nature · added 2026-04-24
Contrasting to the established role of the hypothalamic agouti-related protein (AgRP) neurons in feeding regulation, the neural circuit and signaling mechanisms by which they control energy expenditur Show more
Contrasting to the established role of the hypothalamic agouti-related protein (AgRP) neurons in feeding regulation, the neural circuit and signaling mechanisms by which they control energy expenditure remains unclear. Here, we report that energy expenditure is regulated by a subgroup of AgRP neurons that send non-collateral projections to neurons within the dorsal lateral part of dorsal raphe nucleus (dlDRN) expressing the melanocortin 4 receptor (MC4R), which in turn innervate nearby serotonergic (5-HT) neurons. Genetic manipulations reveal a bi-directional control of energy expenditure by this circuit without affecting food intake. Fiber photometry and electrophysiological results indicate that the thermo-sensing MC4R Show less
📄 PDF DOI: 10.1038/s41467-021-23846-x
MC4R
Guobin Xia, Yong Han, Fantao Meng +7 more · 2021 · Molecular psychiatry · Nature · added 2026-04-24
The high comorbidity between obesity and mental disorders, such as depression and anxiety, often exacerbates metabolic and neurological symptoms significantly. However, neural mechanisms that underlie Show more
The high comorbidity between obesity and mental disorders, such as depression and anxiety, often exacerbates metabolic and neurological symptoms significantly. However, neural mechanisms that underlie reciprocal control of feeding and mental states are largely elusive. Here we report that melanocortin 4 receptor (MC4R) neurons located in the dorsal bed nucleus of the stria terminus (dBNST) engage in the regulation of mentally associated weight gain by receiving GABAergic projections from hypothalamic AgRP neurons onto α5-containing GABA Show less
📄 PDF DOI: 10.1038/s41380-021-01053-w
MC4R
Charlotte Martin, Luis E Gimenez, Savannah Y Williams +13 more · 2021 · Journal of medicinal chemistry · ACS Publications · added 2026-04-24
The melanocortin receptors (MC1R-MC5R) belong to class A G-protein-coupled receptors (GPCRs) and are known to have receptor-specific roles in normal and diseased states. Selectivity for MC4R is of par Show more
The melanocortin receptors (MC1R-MC5R) belong to class A G-protein-coupled receptors (GPCRs) and are known to have receptor-specific roles in normal and diseased states. Selectivity for MC4R is of particular interest due to its involvement in various metabolic disorders, including obesity, feeding regulation, and sexual dysfunctions. To further improve the potency and selectivity of MC4R (ant)agonist peptide ligands, we designed and synthesized a series of cyclic peptides based on the recent crystal structure of MC4R in complex with the well-characterized antagonist Show less
no PDF DOI: 10.1021/acs.jmedchem.0c01620
MC4R
Wenyu Ding, Changjiang Zhang, Baisong Wang +7 more · 2021 · Science China. Life sciences · Springer · added 2026-04-24
Cenpj is a centrosomal protein located at the centrosomes and the base of cilia, it plays essential roles in regulating neurogenesis and cerebral cortex development. Although centrosomal and cilium dy Show more
Cenpj is a centrosomal protein located at the centrosomes and the base of cilia, it plays essential roles in regulating neurogenesis and cerebral cortex development. Although centrosomal and cilium dysfunction are one of the causes of obesity, insulin resistance, and type 2 diabetes, the role that Cenpj plays in the regulation of body weight remains unclear. Here, we deleted Cenpj by crossing Cenpj Show less
no PDF DOI: 10.1007/s11427-020-1767-5
MC4R
Qing Ding, Yuanhao Wu, Wei Liu · 2021 · Medicine · added 2026-04-24
To explore the possible molecular mechanism of reproductive toxicity of Tripterygium wilfordii from the perspective of network pharmacology and bioinformatics.The compounds of T wilfordii were obtaine Show more
To explore the possible molecular mechanism of reproductive toxicity of Tripterygium wilfordii from the perspective of network pharmacology and bioinformatics.The compounds of T wilfordii were obtained by querying the relevant Chinese medicine database, the effective compounds were screened and the corresponding targets were obtained, and then compared with the reproductive toxicities related to disease targets obtained from the disease gene database to infer the potential toxic targets of reproductive toxicity of T wilfordii. Then, the key targets of reproductive toxicity of T wilfordii were screened using Search Tool for the Retrieval of Interacting Genes/Protein and Cytoscape. The gene ontology function and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis, as well as module analysis, were performed on the key targets using Database for Annotation, Visualization, and Integrated Discovery and Cytoscape, respectively. Finally, the network between effective compounds-toxic targets was conducted to see how the compounds interacted.A total of 48 effective compounds and 482 potential toxic targets related to the reproductive toxicity of T wilfordii were screened. The enrichment analysis results showed that the key targets were mainly enriched in biological processes such as response to drug, ionotropic glutamate receptor signaling pathway, and KEGG pathways such as neuroactive ligand-receptor interaction, cAMP signaling pathway. In the protein-protein interaction network of potential toxic targets, there were 78 key targets such as TP53, INS, IL6, AGT, ADCY3, and so on. Enrichment analysis of the top module with 19 genes from module analysis indicated that T wilfordii might cause reproductive toxicity by gene ontology terms and KEGG pathways such as regulation of vasoconstriction, G-protein coupled receptor signaling pathway, inflammatory response, cAMP signaling pathway, and so on. In the network between effective compounds of T wilfordii and key targets, there were 5 compounds with high degree including Tingenone, Wilfordic Acid, Abruslactone A, Nobilin, and Wilforlide B.The complex molecular mechanism of reproductive toxicity of T wilfordii can be preliminarily elucidated with the help of the network pharmacology method, and the analysis results can provide some reference for the further mechanism research of reproductive toxicity of T wilfordii. Show less
📄 PDF DOI: 10.1097/MD.0000000000026197
ADCY3
Shi Yao, Hao Wu, Jing-Miao Ding +5 more · 2021 · International journal of obesity (2005) · Nature · added 2026-04-24
Childhood obesity is one of the most common and costly nutritional problems with high heritability. The genetic mechanism of childhood obesity remains unclear. Here, we conducted a transcriptome-wide Show more
Childhood obesity is one of the most common and costly nutritional problems with high heritability. The genetic mechanism of childhood obesity remains unclear. Here, we conducted a transcriptome-wide association study (TWAS) to identify novel genes for childhood obesity. By integrating the GWAS summary of childhood body mass index (BMI), we conducted TWAS analyses with pre-computed gene expression weights in 39 obesity priority tissues. The GWAS summary statistics of childhood BMI were derived from the early growth genetics consortium with 35,668 children from 20 studies. We identified 15 candidate genes for childhood BMI after Bonferroni corrections. The most significant gene, ADCY3, was identified in 13 tissues, including adipose, brain, and blood. Interestingly, eight genes were only identified in the specific tissue, such as FAIM2 in the brain (P = 2.04 × 10 Our study identified multiple candidate genes for childhood BMI, providing novel clues for understanding the genetic mechanism of childhood obesity. Show less
no PDF DOI: 10.1038/s41366-021-00780-y
ADCY3
Meng Shao, Fang Wu, Jie Zhang +8 more · 2021 · Medicine · added 2026-04-24
Tuberculosis (TB) is one of the leading causes of childhood morbidity and death globally. Lack of rapid, effective non-sputum diagnosis and prediction methods for TB in children are some of the challe Show more
Tuberculosis (TB) is one of the leading causes of childhood morbidity and death globally. Lack of rapid, effective non-sputum diagnosis and prediction methods for TB in children are some of the challenges currently faced. In recent years, blood transcriptional profiling has provided a fresh perspective on the diagnosis and predicting the progression of tuberculosis. Meanwhile, combined with bioinformatics analysis can help to identify the differentially expressed genes (DEGs) and functional pathways involved in the different clinical stages of TB. Therefore, this study investigated potential diagnostic markers for use in distinguishing between latent tuberculosis infection (LTBI) and active TB using children's blood transcriptome data.From the Gene Expression Omnibus database, we downloaded two gene expression profile datasets (GSE39939 and GSE39940) of whole blood-derived RNA sequencing samples, reflecting transcriptional signatures between latent and active tuberculosis in children. GEO2R tool was used to screen for DEGs in LTBI and active TB in children. Database for Annotation, Visualization and Integrated Discovery tools were used to perform Gene Ontology enrichment and Kyoto Encyclopedia of Genes and Genomes pathway analysis. STRING and Cytoscape analyzed the protein-protein interaction network and the top 15 hub genes respectively. Receiver operating characteristics curve was used to estimate the diagnostic value of the hub genes.A total of 265 DEGs were identified, including 79 upregulated and 186 downregulated DEGs. Further, 15 core genes were picked and enrichment analysis revealed that they were highly correlated with neutrophil activation and degranulation, neutrophil-mediated immunity and in defense response. Among them TLR2, FPR2, MMP9, MPO, CEACAM8, ELANE, FCGR1A, SELP, ARG1, GNG10, HP, LCN2, LTF, ADCY3 had significant discriminatory power between LTBI and active TB, with area under the curves of 0.84, 0.84, 0.84, 0.80, 0.87, 0.78, 0.88, 0.84, 0.86, 0.82, 0.85, 0.85, 0.79, and 0.88 respectively.Our research provided several genes with high potential to be candidate gene markers for developing non-sputum diagnostic tools for childhood Tuberculosis. Show less
📄 PDF DOI: 10.1097/MD.0000000000023207
ADCY3
Yan Gao, Ning Wu, Shuai Wang +3 more · 2021 · Breast cancer research and treatment · Springer · added 2026-04-24
HER2-positive breast cancer patients benefit from HER2-targeted therapies, among which the most commonly used is trastuzumab. However, acquired resistance typically happens within one year. The cellul Show more
HER2-positive breast cancer patients benefit from HER2-targeted therapies, among which the most commonly used is trastuzumab. However, acquired resistance typically happens within one year. The cellular heterogeneity of it is less clear. Here we generated trastuzumab-resistant cells in two HER2-positive breast cancer cell lines, SK-BR-3 and BT-474. Cells at different time points during the resistance induction were examined by exome sequencing to study changes of genomic alterations over time. Single cell-targeted sequencing was also used to identify resistance-associated concurrent mutations. We found a rapid increase of copy number variation (CNV) regions and gradual accumulation of single nucleotide variations (SNVs). On the pathway level, non-synonymous SNVs for SK-BR-3 cells were enriched in the MAPK signaling pathway, while for BT-474 cells they were enriched in mTOR and PI3K-Akt signaling pathways. However, all of the three signaling pathways were in the downstream of the HER2 kinase. Putative trastuzumab-resistance-associated SNVs included AIFM1 P548L and ERBB2 M833R in SK-BR-3 cells, and ADAMTS19 V451L, OR5M9 D230N, COL9A1 R627T, and ITGA7 H911Q in BT-474 cells. Single-cell-targeted sequencing identified several concurrent mutations. By validation, we found that concurrent mutations (AIFM1 P548L and IL1RAPL2 S546C in SK-BR-3 cells, MFSD11 L242I and ANAPC4 E16K in BT-474 cells) led to a decrease of trastuzumab sensitivity. Taken together, our study revealed a common pathway level trastuzumab-resistance mechanism for HER2-positive breast cancer cells. In addition, our identification of concurrent SNVs associated with trastuzumab-resistance may be indicative of potential targets for the treatment of trastuzumab-resistant breast cancer patients. Show less
📄 PDF DOI: 10.1007/s10549-021-06237-0
ANAPC4
Qi Jiang, Ye Pan, Ping Li +6 more · 2021 · Frontiers in endocrinology · Frontiers · added 2026-04-24
This study aims to characterize the expression of ANGPTL4 in ovarian granulosa cells (GCs) and its association with polycystic ovary syndrome (PCOS). This study included 104 PCOS patients and 112 wome Show more
This study aims to characterize the expression of ANGPTL4 in ovarian granulosa cells (GCs) and its association with polycystic ovary syndrome (PCOS). This study included 104 PCOS patients and 112 women in control group undergoing The RT-qPCR results showed that ANGPTL4 expression in the control group was significantly lower than that in the PCOS group ( Our study revealed higher ANGPTL4 expression in ovarian GCs with PCOS. Its association with glucose and lipid metabolism showed that ANGPTL4 might play an important role in PCOS metabolism and pathogenesis. Show less
📄 PDF DOI: 10.3389/fendo.2021.799833
ANGPTL4
Xingyue Yang, Wenyan Sun, Qian Wu +9 more · 2021 · Nutrients · MDPI · added 2026-04-24
Use of folic acid (FA) during early pregnancy protects against birth defects. However, excess FA has shown gender-specific neurodevelopmental toxicity. Previously, we fed the mice with 2.5 times the r Show more
Use of folic acid (FA) during early pregnancy protects against birth defects. However, excess FA has shown gender-specific neurodevelopmental toxicity. Previously, we fed the mice with 2.5 times the recommended amount of FA one week prior to mating and during the pregnancy and lactation periods, and detected the activated expression of Show less
📄 PDF DOI: 10.3390/nu14010066
ANGPTL4
Jung-Chien Cheng, Lanlan Fang, Yuxi Li +11 more · 2021 · Communications biology · Nature · added 2026-04-24
Insufficient invasion of trophoblast cells into the uterine decidua is associated with preeclampsia (PE). G protein-coupled estrogen receptor (GPER) is a membrane estrogen receptor involved in non-gen Show more
Insufficient invasion of trophoblast cells into the uterine decidua is associated with preeclampsia (PE). G protein-coupled estrogen receptor (GPER) is a membrane estrogen receptor involved in non-genomic estrogen signaling. GPER is expressed in human trophoblast cells and downregulated GPER levels are noted in PE. However, to date, the role of GPER in trophoblast cells remains largely unknown. Here, we applied RNA sequencing (RNA-seq) to HTR-8/SVneo human trophoblast cells in response to G1, an agonist of GPER, and identified angiopoietin-like 4 (ANGPTL4) as a target gene of GPER. Treatment of trophoblast cells with G1 or 17β-estradiol (E2) activated Yes-associated protein (YAP), the major downstream effector of the Hippo pathway, via GPER but in a mammalian STE20-like protein kinase 1 (MST1)-independent manner. Using pharmacological inhibitors as well as loss- and gain-of-function approaches, our results revealed that YAP activation was required for GPER-stimulated ANGPTL4 expression. Transwell invasion assays demonstrated that activation of GPER-induced ANGPTL4 promoted cell invasion. In addition, the expression levels of GPER, YAP, and ANGPTL4 were downregulated in the placenta of patients with PE. Our findings reveal a mechanism by which GPER exerts its stimulatory effect on human trophoblast cell invasion by upregulating YAP-mediated ANGPTL4 expression. Show less
📄 PDF DOI: 10.1038/s42003-021-02816-5
ANGPTL4